GT Medical Technologies, Inc.
GT Medical Technologies is dedicated to improving the lives of patients with brain tumors through innovative treatments such as GammaTile Therapy, a Surgically Targeted Radiation Therapy (STaRT). The company focuses on advancing brain tumor treatment options, supporting clinical research, and expanding access to GammaTile Therapy across top brain tumor centers in the United States.
Industries
Nr. of Employees
medium (51-250)
GT Medical Technologies, Inc.
GT Medical Technologies, 1234 Innovation Drive, City, State, ZIP
Patents
Method for preparing particles of radioactive powder containing Cesium-131 for use in brachytherapy sources
US-7316644-B2
View Details
Method for preparing particles of radioactive powder containing Cesium-131 for use in brachytherapy sources
US-7316644-B2
View DetailsProducts
Implantable bioresorbable collagen tile with embedded cesium-131 sources
A conformable, bioresorbable collagen tile containing uniformly spaced cesium-131 radiation sources intended for permanent implantation in the resection cavity to deliver localized radiation.
Implantable bioresorbable collagen tile with embedded cesium-131 sources
A conformable, bioresorbable collagen tile containing uniformly spaced cesium-131 radiation sources intended for permanent implantation in the resection cavity to deliver localized radiation.
Services
Onboarding, proctoring, and education for neurosurgeons and radiation oncologists on intraoperative placement and clinical integration of the implantable therapy.
Sponsorship and coordination of randomized trials and observational registries assessing intraoperative brachytherapy in multiple enrolling institutions.
Online tool to estimate postoperative cavity surface area and calculate the number of implant tiles required based on tumor dimensions and assumed cavity contraction.
Operational support for hospital ordering, returns processing, and customer inquiries via a dedicated customer service channel.
Onboarding, proctoring, and education for neurosurgeons and radiation oncologists on intraoperative placement and clinical integration of the implantable therapy.
Sponsorship and coordination of randomized trials and observational registries assessing intraoperative brachytherapy in multiple enrolling institutions.
Online tool to estimate postoperative cavity surface area and calculate the number of implant tiles required based on tumor dimensions and assumed cavity contraction.
Operational support for hospital ordering, returns processing, and customer inquiries via a dedicated customer service channel.
Expertise Areas
- Surgically targeted radiation therapy (intraoperative brachytherapy)
- Clinical trial management and multi-center registries
- Radiation dosimetry and treatment planning
- Intraoperative device implantation and surgical workflow integration
Key Technologies
- Intracranial brachytherapy
- Cesium-131 radioisotope sources
- Bioresorbable conformable collagen carriers
- Intraoperative implantable radiation devices
News & Updates
GT Medical Technologies launched a new program to designate top brain tumor centers as GammaTile® Centers of Excellence, starting with the USC Brain Tumor Center.
The company secured funding to support the expansion of GammaTile Therapy for patients with operable brain tumors across the United States.
A news article highlighting the potential benefits of GammaTile Therapy in improving survival for brain tumor patients.
A patient story about the use of GammaTile in a case where standard treatments had failed.
The enrollment of the 100th patient in the ROADS clinical trial signifies a major milestone in GammaTile research.
Celebrating the treatment of over 1,300 newly diagnosed malignant and recurrent brain tumor patients with GammaTile.
GT Medical Technologies launched a new program to designate top brain tumor centers as GammaTile® Centers of Excellence, starting with the USC Brain Tumor Center.
The company secured funding to support the expansion of GammaTile Therapy for patients with operable brain tumors across the United States.
A news article highlighting the potential benefits of GammaTile Therapy in improving survival for brain tumor patients.
A patient story about the use of GammaTile in a case where standard treatments had failed.
The enrollment of the 100th patient in the ROADS clinical trial signifies a major milestone in GammaTile research.
Celebrating the treatment of over 1,300 newly diagnosed malignant and recurrent brain tumor patients with GammaTile.